Schedule I finds itself embroiled in a copyright dispute, but fans have retaliated by review-bombing the accuser's games instead. Read on to understand the copyright allegations and learn about Schedule I's upcoming update.
Schedule I Recent Updates
Copyright Accuser Suffers Steam Backlash
Indie drug trade simulator Schedule I faces copyright infringement accusations from Movie Games S.A., creators of The Drug Dealer Simulator series. As reported by the Polish Press Agency on April 3, the developer claims Schedule I may have copied plot elements, gameplay mechanics, and user interface designs from their franchise.
The gaming community has responded strongly, with fans overwhelming both Drug Dealer Simulator titles with negative Steam reviews. The situation escalated quickly, resulting in "Overwhelmingly Negative" and "Mostly Negative" ratings for the original and sequel respectively.
Reviewers largely condemn what they perceive as corporate bullying against an indie developer, noting hypocrisy as previous similar games went unchallenged. The backlash contrasts with the series' reputation as acclaimed criminal management simulations.
Schedule I offers a cooperative crime experience where players ascend from street-level dealing to criminal empire building. Since its March 25 Early Access launch, it has earned "Overwhelmingly Positive" reception and currently ranks as Steam's #2 top seller - surpassing anticipated titles like Monster Hunter Wilds. SteamDB reports peak concurrent players exceeding 459,000.
Our team found Schedule I delivers an unexpectedly compelling crime simulation experience. For our complete evaluation of its Early Access version, see our coverage below!
